Tiziana Life Sciences (TLSA)

Search documents
Tiziana Life Sciences (TLSA) Investor Presentation - Slideshow
2021-01-19 19:09
/ tiziana LIFE SCIENCES January 2021 Corporate Presentation www.tizianalifesciences.com NASDAQ: TLSA AIM: TILS Disclaimer And Forward Looking Statements The content of this presentation has been prepared for the purpose of providing general information about, and an overview of, the Company and its business. It is not intended to be a complete review of all matters concerning the Company and nor has it been independently verified. Whilst the presentation has been prepared in good faith and the Company has t ...
Tiziana Life Sciences (TLSA) Investor Presentation - Slideshow
2020-09-02 21:08
An Innovative Platform in Oral, Nasal and Inhalation for Monoclonal Antibody Administration Proprietary inhalation delivery of anti-IL-6R mAb for COVID-19 treatment Advanced clinical programs in Crohn's Disease, progressive Multiple Sclerosis, and Hepatocellular Carcinoma August 2020 Corporate Presentation https://www.tizianalifesciences.com/ NASDAQ: TLSA AIM: TILS DISCLAIMER AND FORWARD LOOKING STATEMENTS 2 The content of this presentation has been prepared for the purpose of providing general information ...
Tiziana Life Sciences (TLSA) - 2019 Q4 - Annual Report
2020-06-17 21:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITI ...
Tiziana Life Sciences (TLSA) - 2018 Q4 - Annual Report
2019-04-04 10:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITI ...